LEGN
LEGN clinical trials: Legend Biotech Corp
Every trial on ClinicalTrials.gov where Legend Biotech Corp is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 4
- Trials linked
- 3
- As lead sponsor
- 1
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
LEGN on the catalyst calendar · LEGN registry changes
- Primary completion Dec 2027Sponsor estimatePhase 1NCT05539430Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric...Legend Biotech USA Inc · Gastric CancerActive, not recruitingLEGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2027Sponsor estimatePhase 1NCT05680922DLL3-Directed Chimeric Antigen Receptor T-cells in Subjects With Extensive Stage Small Cell Lung CancerLegend Biotech USA Inc · Small Cell Lung Cancer Extensive StageActive, not recruitingLEGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2023Sponsor estimatePhase 1NCT04712864Study of CD4-Targeted Chimeric Antigen Receptor T-Cells (CD4- CAR-T) in Subjects With Relapsed or Refractory T-Cell LymphomaLegend Biotech USA Inc · T-Cell LymphomaUnknown statusLEGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 27, 2022ActualNo phase registeredNCT04035226A Study of Real-life Current Standards of Care in Patients With Relapsed and/or Refractory Multiple Myeloma Who Received at Least 3...Janssen-Cilag Ltd. · Multiple MyelomaCompletedJNJLeadLEGNCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 4 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner